Wellgistics Health (NASDAQ:WGRX) Rating Increased to Hold at Wall Street Zen

Key Points

• Wellgistics Health's rating was upgraded from a "sell" to a "hold" by Wall Street Zen, indicating improved confidence in the company's prospects.
• The company's share price opened at $1.32, with a 12-month range between $0.62 and $7.04.
• In its latest quarterly earnings report, Wellgistics Health reported a loss of ($0.11) earnings per share and a revenue of $7.79 million.

Wellgistics Health (NASDAQ:WGRX - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a report released on Friday.

Wellgistics Health Trading Down 3.6%

Shares of NASDAQ WGRX opened at $1.32 on Friday. Wellgistics Health has a 12-month low of $0.62 and a 12-month high of $7.04. The company has a debt-to-equity ratio of 11.16, a current ratio of 0.32 and a quick ratio of 0.11. The firm has a fifty day moving average of $0.98.

Wellgistics Health (NASDAQ:WGRX - Get Free Report) last posted its quarterly earnings data on Tuesday, August 19th. The company reported ($0.11) earnings per share for the quarter. The business had revenue of $7.79 million for the quarter.

Wellgistics Health Company Profile

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.